Rights issue in Biotage AB (SE) — SEK 48 million

Carnegie acted as sole adviser in the rights issue in Biotage AB. Slightly more than 8 million new shares have been issued, bringing to the company approximately SEK 48.3 million, excluding costs. Biotage AB is a leading supplier of complete solutions for Medicinal Chemistry Research and Applied Genetic Analysis.November, 2005.